US Stock MarketDetailed Quotes
CAH Cardinal Health
- 112.410
- +0.480+0.43%
Close Oct 18 16:00 ET
- 112.410
- 0.0000.00%
Post 16:20 ET
27.20BMarket Cap32.58P/E (TTM)
112.560High111.040Low1.37MVolume111.890Open111.930Pre Close153.63MTurnover0.57%Turnover Ratio32.58P/E (Static)241.96MShares115.51852wk High-8.47P/B27.06BFloat Cap88.47252wk Low2.01Dividend TTM240.74MShs Float115.518Historical High1.79%Div YieldTTM1.36%Amplitude14.535Historical Low112.172Avg Price1Lot Size
Cardinal Health Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 32.28%3.76B | 140.67%2.08B | -103.60%-49M | 99.16%1.19B | 2,269.57%545M | -10.43%2.84B | -71.66%863M | 424.82%1.36B | -50.04%597M | 103.56%23M |
| Net income from continuing operations | 157.70%853M | 7,700.00%234M | -25.36%259M | 372.31%354M | -94.59%6M | 135.33%331M | -97.73%3M | 124.96%347M | -365.31%-130M | -59.19%111M |
| Depreciation and amortization | 2.60%710M | 5.68%186M | 1.14%177M | 2.94%175M | 0.58%172M | 0.00%692M | -1.68%176M | -3.31%175M | 3.66%170M | 1.79%171M |
| Deferred tax | -160.00%-104M | ---- | ---- | ---- | ---- | -385.71%-40M | ---- | ---- | ---- | ---- |
| Change In working capital | 230.42%1.51B | 394.87%1.74B | -179.18%-616M | 396.63%617M | 50.86%-228M | -62.23%457M | -85.44%351M | 184.98%778M | 39.36%-208M | 58.94%-464M |
| -Change in receivables | -4.84%-996M | -66.82%-734M | -44.99%225M | -30.66%-537M | 109.84%50M | 32.38%-950M | -107.55%-440M | 147.34%409M | -257.39%-411M | -137.38%-508M |
| -Change in inventory | 370.63%1.12B | 314.33%2.49B | 84.63%1.17B | -7.25%-1.48B | -300.38%-1.06B | 65.78%-412M | 312.77%600M | 212.48%631M | -494.40%-1.38B | -104.65%-264M |
| -Change in payables and accrued expense | -23.53%1.39B | -107.85%-15M | -665.65%-2.01B | 66.43%2.63B | 152.92%779M | -52.37%1.82B | -93.42%191M | -115.43%-262M | 39,450.00%1.58B | 139.14%308M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 32.28%3.76B | 140.67%2.08B | -103.60%-49M | 99.16%1.19B | 2,269.57%545M | -10.43%2.84B | -71.66%863M | 424.82%1.36B | -50.04%597M | 103.56%23M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -307.27%-1.85B | 180.58%166M | -1,929.67%-1.85B | -20.69%-105M | 10.00%-63M | -180.07%-454M | -0.98%-206M | -106.82%-91M | -85.11%-87M | -108.12%-70M |
| Net PPE purchase and sale | -6.40%-499M | 7.73%-191M | 4.59%-104M | -32.94%-113M | -33.82%-91M | -31.74%-469M | -43.75%-207M | 89.20%-109M | -109.84%-85M | -1.49%-68M |
| Net business purchase and sale | -11,710.00%-1.18B | --2M | -11,820.00%-1.19B | ---- | ---- | -101.11%-10M | --0 | -101.08%-10M | ---- | ---- |
| Net investment purchase and sale | -776.00%-169M | 35,400.00%355M | -2,067.86%-551M | 50.00%-1M | 1,500.00%28M | 13.64%25M | 102.63%1M | -33.33%28M | -112.50%-2M | -200.00%-2M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -307.27%-1.85B | 180.58%166M | -1,929.67%-1.85B | -20.69%-105M | 10.00%-63M | -180.07%-454M | -0.98%-206M | -106.82%-91M | -85.11%-87M | -108.12%-70M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 72.24%-847M | -45.10%-859M | 210.39%1.03B | 2.49%-353M | 42.73%-666M | -23.87%-3.05B | -42.65%-592M | -174.71%-934M | 18.47%-362M | 7.99%-1.16B |
| Net issuance payments of debt | 161.49%356M | -9,400.00%-760M | 302.69%1.13B | -33.33%-8M | 0.00%-7M | 34.58%-579M | 97.22%-8M | -11,060.00%-558M | -20.00%-6M | 98.81%-7M |
| Net common stock issuance | 62.50%-750M | --0 | --0 | 0.00%-250M | 50.00%-500M | -100.00%-2B | ---500M | -25.00%-250M | 16.67%-250M | -100.00%-1B |
| Cash dividends paid | 4.95%-499M | 3.17%-122M | 4.69%-122M | 3.88%-124M | 7.75%-131M | 6.08%-525M | 5.97%-126M | 5.88%-128M | 7.86%-129M | 4.70%-142M |
| Net other financing activities | -13.21%46M | -45.24%23M | 1,000.00%22M | 26.09%29M | -100.00%-28M | 378.95%53M | 500.00%42M | 100.00%2M | 2,200.00%23M | 50.00%-14M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 72.24%-847M | -45.10%-859M | 210.39%1.03B | 2.49%-353M | 42.73%-666M | -23.87%-3.05B | -42.65%-592M | -174.71%-934M | 18.47%-362M | 7.99%-1.16B |
| Net cash flow | ||||||||||
| Beginning cash position | -14.10%4.08B | -6.82%3.72B | 25.64%4.59B | 10.37%3.85B | -14.29%4.04B | 40.30%4.75B | 69.35%3.99B | 15.60%3.65B | 41.78%3.49B | 38.45%4.72B |
| Current changes in cash | 261.27%1.07B | 2,029.23%1.38B | -357.44%-865M | 393.92%731M | 84.79%-184M | -151.68%-661M | -97.32%65M | 141.84%336M | -78.98%148M | -15.46%-1.21B |
| Effect of exchange rate changes | -12.50%-9M | 71.43%-2M | ---8M | -57.14%6M | 66.67%-5M | 68.00%-8M | 41.67%-7M | --0 | 333.33%14M | -200.00%-15M |
| End cash Position | 25.93%5.13B | 25.93%5.13B | -6.82%3.72B | 25.64%4.59B | 10.37%3.85B | -14.10%4.08B | -14.10%4.08B | 69.35%3.99B | 15.60%3.65B | 41.78%3.49B |
| Free cash flow | 37.58%3.25B | 191.64%1.88B | -112.86%-161M | 109.96%1.08B | 1,063.83%453M | -15.24%2.36B | -77.58%646M | 349.90%1.25B | -54.33%512M | 93.41%-47M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data